Key facts
- This page summarizes Clarke Neumann's Form 4 filing for BIORA THERAPEUTICS, INC. (BIORQ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Aug 2024, 16:05.
Clarke Neumann - 15 Aug 2024 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)
- Reporting relationship
- Officer
- Issuer ticker
- BIORQ
- Reported as of
- 15 Aug 2024
- Net transaction value
- -$17,841
- SEC form
- 4
- Accepted by SEC
- 16 Aug 2024, 16:05:05 UTC
- Prior SEC filing
- 15 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Clarke Neumann
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Clarke Neumann filed Form 4 for BIORA THERAPEUTICS, INC. (BIORQ) on 16 Aug 2024.
Change
- Previous filing in this sequence was filed on 15 Feb 2024.
- Current net transaction value: -$17,841.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIOR
transaction
Common Stock
Tax liability
- Transaction value
- $17,841
- Shares
- -26,629
- Change %
- -5.4%
- Price
- $0.6700
- Shares after
- 465,564
- Date
- 15 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested restricted stock units.